Blood-based Early Detection Tests for Gastric Cancer Program, Pilot Clinical Study (Phase I)

Blood-based Early Detection Tests for Gastric Cancer Program, Pilot Clinical Study (Phase I) - Early Detection Tests for Gastric Cancer Program

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000002209

Enrollment

250

Registered

2009-07-17

Start date

2009-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: "Subject has been screened for gastric cancer by endoscopy and confirmed as not having gastric cancer."or "Subject has been confirmed as having gastric cancer." Subject agrees to have cancer related blood test (excluding DNA/genetic tests) in the blood sample. Subject is willing to provide blood. Subject is willing to provide demographic and medical history information. Subject is competent to give written informed consent.

Exclusion criteria

Exclusion criteria: Subject was taking experimental drug or anticancer drug within the past 30 days. Subject has been confirmed as having cancer in the past. Subject was confirmed as having cancer excluding gastric cancer at present. Major trauma or surgery within the past 3 months before study procedure. Subject is considered by the investigator to be an unsuitable candidate for this study. Known or suspected infection with human immunodeficiency virus or infectious hepatitis.

Design outcomes

Primary

Measure	Time frame
Sensitivity and specificity of biomarhkers	—

Countries

Japan

Contacts

Public ContactMasahiro Sakabe

Alere Medical Co., Ltd. Technical Support

Outcome results